Citation Impact
Citing Papers
Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study
2003
Hepatorenal syndrome: the 8th international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group
2012
Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized study
2002
Circulatory function and hepatorenal syndrome in cirrhosis†
2005
Acute kidney injury
2012 Standout
Liver fibrosis
2005 Standout
Human serum albumin: From bench to bedside
2011
The effect of 1 month of therapy with midodrine, octreotide‐LAR and albumin in refractory ascites: a pilot study
2009
Management of adult patients with ascites due to cirrhosis†
2004
Descending control of pain
2002 Standout
Pathogenesis of Hepatorenal Syndrome: Implications for Therapy
2015
Acute-on-Chronic Liver Failure: Pathophysiological Basis of Therapeutic Options
2002
Midodrine and Clonidine in Patients With Cirrhosis and Refractory or Recurrent Ascites: A Randomized Pilot Study
2013
Diagnosis and treatment of acute renal failure in patients with cirrhosis
2007
Albumin–drug interaction and its clinical implication
2013 Standout
Renal Failure in Cirrhosis
2009
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
The role of portosystemic shunting in the management of portal hypertension
1992
Seasonal changes in plasma glucocorticoid concentrations in free-living vertebrates
2002 Standout
Acute Kidney Injury: New Concepts
2008
Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: A pilot study
2002
Mechanisms of Actions of Inhaled Anesthetics
2003 Standout
Vascular disorders of the liver # †
2008 Standout
Terlipressin therapy for reversal of type 1 hepatorenal syndrome: A meta‐analysis of randomized controlled trials
2010
Acute renal failure in patients with cirrhosis: Perspectives in the age of MELD
2003
Acute kidney injury
2019 Standout
Management of Cirrhosis and Ascites
2004
Octreotide/Midodrine Therapy Significantly Improves Renal Function and 30-Day Survival in Patients with Type 1 Hepatorenal Syndrome
2007
Daily and Seasonal Variation in Response to Stress in Captive Starlings (Sturnus vulgaris): Corticosterone
2000
Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome
2007
Hepatorenal Disorders
2015
Management of adult patients with ascites caused by cirrhosis†
1998
Acute kidney injury in cirrhosis
2008
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial
2015
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost
2005
Noradrenalin vs terlipressin in patients with hepatorenal syndrome: A prospective, randomized, unblinded, pilot study
2007
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document
2000 Standout
Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice
2012
Advances in alcoholic liver disease
2003
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Albumin Therapy in Clinical Practice
2005
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
2008 Standout
An Open Label, Pilot, Randomized Controlled Trial of NoradrenalineVersusTerlipressin in the Treatment of Type 1 Hepatorenal Syndrome and Predictors of Response
2008
Midodrine in patients with cirrhosis and refractory or recurrent ascites: A randomized pilot study
2011
Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management
2003
Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study
2000
On a Proposed Theory for the Mechanism of Action of Serotonin in Brain
1962
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
1965 Standout
Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis
2007
Effect of Nitrous Oxide on Excitatory and Inhibitory Synaptic Transmission in Hippocampal Cultures
1998
Urinary Biomarkers of Acute Kidney Injury in Patients with Liver Cirrhosis
2014
Early Exposure to Common Anesthetic Agents Causes Widespread Neurodegeneration in the Developing Rat Brain and Persistent Learning Deficits
2003 Standout
Alcoholic Hepatitis
2009
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Portal Hypertension and Its Complications
2008
Terlipressin versus other vasoactive drugs for hepatorenal syndrome
2017
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Works of A Maffei-Faccioli being referenced
Reversal of Type 1 Hepatorenal Syndrome With the Administration of Midodrine and Octreotide
1999
Selective variceal decompression and its role relative to other therapies
1990
Reversal of the reserpine‐induced depletion of brain serotonin by a monoamine oxidase inhibitor
1959